Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,215
Closed -$6.05M 159
2024
Q4
$6.05M Sell
23,215
-3,489
-13% -$1.04M 0.72% 45
2024
Q3
$8.6M Buy
26,704
+1,472
+6% +$482K 1.09% 32
2024
Q2
$7.88M Buy
25,232
+1,640
+7% +$482K 1.06% 29
2024
Q1
$6.71M Buy
23,592
+22,475
+2,012% +$6.58M 0.97% 34
2023
Q4
$322K Buy
1,117
+27
+2% +$7.36K 0.05% 125
2023
Q3
$293K Buy
1,090
+1
+0.1% +$250 0.06% 126
2023
Q2
$242K Buy
+1,089
New +$253K 0.05% 141

Other funds holding AMGN

Bensler's AMGN Position: Q1 2025 in Review

Bensler sold out of Amgen (AMGN) in Q1 2025, closing a stake of 23,215 shares — an estimated $6.05M sold.

Bensler first reported a position in AMGN in Q2 2023 and held it in 7 quarters. The position peaked at $8.6M in Q3 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Bensler reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Bensler sold 23,215 Amgen shares in Q1 2025, an estimated $6.05M.
  • Bensler first reported a position in Amgen in Q2 2023 and held it in 7 quarters.
  • Bensler's Amgen position peaked at $8.6M in Q3 2024.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Bensler's 13F filing for Q1 2025, filed 16 Apr 2025.